COLL vs. HQY

Last updated Apr 2, 2026

Compare and contrast key facts about Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY).

Performance

COLL vs. HQY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY). The values are adjusted to include any dividend payments, if applicable.

COLL vs. HQY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
COLL Collegium Pharmaceutical, Inc.	-28.19%	61.61%	-6.92%	32.67%	24.20%	-6.74%	-2.67%	19.86%	-6.99%	18.56%
HQY HealthEquity, Inc.	-8.98%	-4.52%	44.72%	7.56%	39.33%	-36.54%	-5.89%	24.17%	27.84%	15.15%

Fundamentals

Market Cap COLL : $1.32B HQY : $7.19B
EPS COLL : $1.60 HQY : $2.46
PE Ratio COLL : 20.84 HQY : 33.85
PEG Ratio COLL : 0.50 HQY : 0.24
PS Ratio COLL : 1.68 HQY : 5.55
PB Ratio COLL : 4.38 HQY : 3.41
Total Revenue (TTM) COLL : $780.57M HQY : $1.31B
Gross Profit (TTM) COLL : $463.26M HQY : $913.12M
EBITDA (TTM) COLL : $599.85M HQY : $447.44M

Returns By Period

In the year-to-date period, COLL achieves a -28.19% return, which is significantly lower than HQY's -8.98% return. Over the past 10 years, COLL has underperformed HQY with an annualized return of 5.66%, while HQY has yielded a comparatively higher 12.81% annualized return.

COLL

• 1D: 0.54%
• 1M: -20.07%
• YTD: -28.19%
• 6M: -5.46%
• 1Y: 13.13%
• 3Y*: 11.49%
• 5Y*: 7.30%
• 10Y*: 5.66%

HQY

• 1D: -0.23%
• 1M: 6.99%
• YTD: -8.98%
• 6M: -8.08%
• 1Y: -4.22%
• 3Y*: 12.40%
• 5Y*: 4.13%
• 10Y*: 12.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

COLL vs. HQY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COLL

COLL Risk / Return Rank: 50
COLL Sharpe Ratio Rank: 53
COLL Sortino Ratio Rank: 49
COLL Omega Ratio Rank: 46
COLL Calmar Ratio Rank: 49
COLL Martin Ratio Rank: 52

HQY

HQY Risk / Return Rank: 33
HQY Sharpe Ratio Rank: 35
HQY Sortino Ratio Rank: 31
HQY Omega Ratio Rank: 31
HQY Calmar Ratio Rank: 35
HQY Martin Ratio Rank: 35

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COLL vs. HQY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	COLL	HQY	Difference
Sharpe ratio Return per unit of total volatility	0.34	-0.11	+0.45
Sortino ratio Return per unit of downside risk	0.78	0.10	+0.68
Omega ratio Gain probability vs. loss probability	1.09	1.01	+0.08
Calmar ratio Return relative to maximum drawdown	0.32	-0.16	+0.48
Martin ratio Return relative to average drawdown	1.01	-0.31	+1.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

COLL vs. HQY - Sharpe Ratio Comparison

The current COLL Sharpe Ratio is 0.34, which is higher than the HQY Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of COLL and HQY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	COLL	HQY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.34	-0.11	+0.45
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.18	0.11	+0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.10	0.29	-0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.17	0.32	-0.16

Correlation

The correlation between COLL and HQY is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

COLL vs. HQY - Dividend Comparison

Neither COLL nor HQY has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

COLL vs. HQY - Drawdown Comparison

The maximum COLL drawdown since its inception was -73.59%, which is greater than HQY's maximum drawdown of -60.65%. Use the drawdown chart below to compare losses from any high point for COLL and HQY.

Drawdown Indicators

	COLL	HQY	Difference
Max Drawdown Largest peak-to-trough decline	-73.59%	-60.65%	-12.94%
Max Drawdown (1Y) Largest decline over 1 year	-35.81%	-35.25%	-0.56%
Max Drawdown (5Y) Largest decline over 5 years	-43.99%	-53.29%	+9.30%
Max Drawdown (10Y) Largest decline over 10 years	-65.22%	-60.65%	-4.57%
Current Drawdown Current decline from peak	-33.29%	-27.19%	-6.10%
Average Drawdown Average peak-to-trough decline	-31.16%	-22.92%	-8.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.28%	18.34%	-7.06%

Volatility

COLL vs. HQY - Volatility Comparison

Collegium Pharmaceutical, Inc. (COLL) has a higher volatility of 11.41% compared to HealthEquity, Inc. (HQY) at 6.65%. This indicates that COLL's price experiences larger fluctuations and is considered to be riskier than HQY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	COLL	HQY	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.41%	6.65%	+4.76%
Volatility (6M) Calculated over the trailing 6-month period	27.80%	24.20%	+3.60%
Volatility (1Y) Calculated over the trailing 1-year period	39.31%	37.27%	+2.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	40.23%	39.33%	+0.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	54.38%	44.35%	+10.03%

Financials

COLL vs. HQY - Profitability Comparison

The chart below illustrates the profitability comparison between Collegium Pharmaceutical, Inc. and HealthEquity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

COLL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a gross profit of 128.38M and revenue of 205.45M. Therefore, the gross margin over that period was 62.5%.

HQY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, HealthEquity, Inc. reported a gross profit of 309.15M and revenue of 334.59M. Therefore, the gross margin over that period was 92.4%.

COLL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported an operating income of 59.22M and revenue of 205.45M, resulting in an operating margin of 28.8%.

HQY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, HealthEquity, Inc. reported an operating income of 67.37M and revenue of 334.59M, resulting in an operating margin of 20.1%.

COLL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a net income of 16.96M and revenue of 205.45M, resulting in a net margin of 8.3%.

HQY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, HealthEquity, Inc. reported a net income of 49.74M and revenue of 334.59M, resulting in a net margin of 14.9%.